HK1040201A1 - 包含性激素和環糊精的鼻用噴霧溶液的製備方法 - Google Patents

包含性激素和環糊精的鼻用噴霧溶液的製備方法

Info

Publication number
HK1040201A1
HK1040201A1 HK02102010.0A HK02102010A HK1040201A1 HK 1040201 A1 HK1040201 A1 HK 1040201A1 HK 02102010 A HK02102010 A HK 02102010A HK 1040201 A1 HK1040201 A1 HK 1040201A1
Authority
HK
Hong Kong
Prior art keywords
cyclodextrin
preparing
nasal spray
solution
sex hormones
Prior art date
Application number
HK02102010.0A
Other languages
English (en)
Inventor
G‧方克奈什坦
P‧烏斯裡希
Original Assignee
瑟維爾實驗室
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑟維爾實驗室 filed Critical 瑟維爾實驗室
Publication of HK1040201A1 publication Critical patent/HK1040201A1/zh

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Nanotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02102010.0A 1998-10-14 2002-03-15 包含性激素和環糊精的鼻用噴霧溶液的製備方法 HK1040201A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9812836A FR2784584B1 (fr) 1998-10-14 1998-10-14 Procede de preparation d'une solution pour pulverisation nasale contenant une ou plusieurs hormones sexuelles et une cyclodextrine
PCT/FR1999/002480 WO2000021503A1 (fr) 1998-10-14 1999-10-13 Procede de preparation d'une solution pour pulverisation nasale contenant une ou plusieurs hormones sexuelles et une cyclodextrine

Publications (1)

Publication Number Publication Date
HK1040201A1 true HK1040201A1 (zh) 2002-05-31

Family

ID=9531516

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102010.0A HK1040201A1 (zh) 1998-10-14 2002-03-15 包含性激素和環糊精的鼻用噴霧溶液的製備方法

Country Status (21)

Country Link
EP (1) EP1121100B1 (zh)
JP (1) JP3911125B2 (zh)
KR (1) KR100462441B1 (zh)
CN (1) CN1323198A (zh)
AT (1) ATE237310T1 (zh)
AU (1) AU756441B2 (zh)
BR (1) BR9914532A (zh)
CA (1) CA2346567C (zh)
DE (1) DE69907005T2 (zh)
DK (1) DK1121100T3 (zh)
EA (1) EA003069B1 (zh)
ES (1) ES2197672T3 (zh)
FR (1) FR2784584B1 (zh)
HK (1) HK1040201A1 (zh)
HU (1) HUP0103968A3 (zh)
NO (1) NO20011673D0 (zh)
NZ (1) NZ510776A (zh)
PL (1) PL347322A1 (zh)
PT (1) PT1121100E (zh)
WO (1) WO2000021503A1 (zh)
ZA (1) ZA200102961B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827516B1 (fr) * 2001-07-19 2003-09-19 Servier Lab Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone
EP1661556A4 (en) * 2003-08-20 2010-05-19 Ajinomoto Kk MEDICAL PREPARATION WITH IMPROVED RESOLUTION CHARACTERISTICS
GB2482868A (en) * 2010-08-16 2012-02-22 Franciscus Wilhelmus Henricus Maria Merkus A testosterone liquid spray formulation for oromucosal administration
US8492368B2 (en) * 2011-10-07 2013-07-23 Florida State University Research Foundation Nasal delivery mechanism for prophylactic and post-acute use of progesterone and/or its enantiomer for use in treatment of mild traumatic brain injuries
WO2013107515A1 (en) 2012-01-20 2013-07-25 Okapi Sciences Nv Eye drop composition
RU2753511C2 (ru) * 2017-05-31 2021-08-17 Аратана Терапьютикс, Инк. Композиция глазных капель

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801670A (nl) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
DE4207922A1 (de) * 1992-03-13 1993-09-23 Pharmatech Gmbh Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.

Also Published As

Publication number Publication date
CA2346567C (fr) 2005-06-14
FR2784584A1 (fr) 2000-04-21
EA200100316A1 (ru) 2002-02-28
BR9914532A (pt) 2001-11-06
HUP0103968A3 (en) 2002-06-28
DE69907005T2 (de) 2004-03-18
PL347322A1 (en) 2002-03-25
DE69907005D1 (de) 2003-05-22
DK1121100T3 (da) 2003-07-21
KR20010073214A (ko) 2001-07-31
FR2784584B1 (fr) 2002-09-20
NZ510776A (en) 2002-10-25
JP3911125B2 (ja) 2007-05-09
CN1323198A (zh) 2001-11-21
EP1121100A1 (fr) 2001-08-08
ZA200102961B (en) 2001-11-20
NO20011673L (no) 2001-04-03
KR100462441B1 (ko) 2004-12-17
CA2346567A1 (fr) 2000-04-20
WO2000021503A1 (fr) 2000-04-20
AU6096799A (en) 2000-05-01
ES2197672T3 (es) 2004-01-01
EP1121100B1 (fr) 2003-04-16
PT1121100E (pt) 2003-07-31
ATE237310T1 (de) 2003-05-15
NO20011673D0 (no) 2001-04-03
JP2002527374A (ja) 2002-08-27
EA003069B1 (ru) 2002-12-26
AU756441B2 (en) 2003-01-16
HUP0103968A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
MX9704377A (es) Uso de pramipexole como agente neuroprotector.
EP1015039A4 (en) MEANS OF OXYGEN DELIVERY AND THEIR APPLICATION
ATE302040T1 (de) Ringstent
SG147286A1 (en) Manufacture of polyglumate-therapeutic agent conjugates
MX9800401A (es) Sistema transcorneal de liberacion de medicamentos.
MX9800625A (es) Marcfortinas y paraherquamidas antiparasitarias.
IL133531A0 (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides
AU144045S (en) Nasal mask
MY125565A (en) Intermediates and process for preparing olanzapine
ZA99283B (en) Inhaler for medication.
HK1034523A1 (en) Hemiasterlin analogs
HUP0202666A3 (en) Drug delivery device, especially for the delivery of androgens
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
PL347322A1 (en) Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
AU144046S (en) Nasal mask
GB9618056D0 (en) Process
AU2286199A (en) Pressure regulator for intubation catheter, tracheotomy tube or the like
EP0666078A3 (en) Nasal spray compositions.
ZA972059B (en) Components for inhalation devices.
ZA9811598B (en) A substance or composition for the treatment of cancer.
ZA200206019B (en) A system for the supply of services.
ZA99494B (en) Container for an inhalation anesthetic.
TJ99000565A (en) The pneumatic pump of replacement by e. musabekov
JO2054B1 (en) Zubaydah bath